Quantcast Amputee Rights
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Amputee Rights

Posted on 05/17/2007 05:52:11 | Link | Post Comment
by David E. Williams
Health Business Blog



The New York Times and USA Today had stories on amputees and prostheses today. The front-page Times piece (Debate on Amputee Sprinter: Is He Disabled or Too-Abled?) chronicles the story of a South African who’s been legless from infancy and wants to run in the Olympics. His high-tech carbon fiber Cheetah prostheses, made by Ossur enable him to reach Olympic speeds. Unsurprisingly the track and field governing body wants to ban him for having an unfair advantage, while he and his supporters say he doesn’t have an unfair advantage and should be allowed to compete. The points on each side are interesting as far as they go.

Too bad the article doesn’t mention the cost and general availability of the prosthetics, which is the subject of the USA Today’s piece (Amputees’ reality is out of step with ‘Dancing’), which appears in the Life Section. Without providing any hard statistics, the thrust of the article is that amputees are being denied coverage for prosthetics. Heather Mills, “the estranged wife of former Beatle Paul McCartney” is shown on the TV show Dancing With the Stars, but according to Amputee Support Team of Central Pennsylvania’s Dick Nickle (try saying that name five times fast):

“It’s an inspirational thing she’s doing, but it sometimes creates a false sense of being able to do the same thing based on your income and insurance.”


The article describes the C-Leg, “a limb containing a microprocessor and hydraulics” that is seen by some amputees as a godsend, but costs $60,000, an amount insurers are reportedly often unwilling to pay. Meanwhile Medicare does cover the devices.

We’ll be hearing a lot more about amputees and prostheses; Iraq and Afghanistan veterans will make sure of that. But there’s a great opportunity to demonstrate that medical technology doesn’t have to drive up costs, rather it can drive them down. Nobody can make me believe that the cost of the device can’t fall radically with scale-up. Sure, some of the materials are expensive but hydraulics and especially microprocessors can benefit from experience curve effects that drive costs down over time. That leaves the labor costs associated with the prostheses, especially the time of physicians and other medical personnel. Those costs can be driven down, too, by more efficient deployment in the US or outsourcing to high-skill, low cost facilities in places like India and Thailand. India’s more or less on the way home from Afghanistan anyway.

And let’s not forget about the many more amputees in poorer countries. Seems to me that low cost, high quality prostheses would be a lot more useful technology than the cheap laptops that some are so excited about.




Source: HealthBusinessBlog.com

____________________
Stock Quote or
Examples
Morpheus Trading - Sun Aug 24, 2008 06:22AM
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Thu Aug 28, 2008 02:39AM
NOTE: Please click on the charts below to enlarge them if [read more]
Boucher On The Big Picture - Thu Aug 28, 2008 05:01PM
Market Needs to Show Volume and Breadth To Signal Next M [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.